A Phase III Randomized Trial Assessing the Utility of a Test Dose Program With Taxanes

Completed · Phase 3

Conditions studied: Supportive, Ill-defined Sites

In brief

The purpose of this study are to determine whether a test dose program for taxanes will reduce the rate and/or severity of hypersensitivity reactions (HSR); and to determine whether a test dose program for taxanes will result in cost reduction due to decreased drug wastage.

Key facts

Study ID

NCT00277043

Run by

New Mexico Cancer Research Alliance

People needed

200

Starts

2002-06-01

Expected to finish

2005-09-01

Last updated by the study team

2011-09-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient must sign informed consent
• Patient must be greater than 18 years of age
• Patient must be receiving his/her first dose of either Taxol or Taxotere
• Patient must have received routine premedications for hypersensitivity reactions

Where it is running

• University of New Mexico — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.